Hereditary Cancer in Clinical Practice · 2015 · 37 citations · 29 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMolecular OncologyTumor ProgressionCancer GenomicsCancer ProgressionEndocrine Tumor GeneticsOncogene MutationsThyroid CancerCancer Recurrence RiskCancer Risk AssessmentExact Test For Hardy-weinberg EquilibriumFollicular Thyroid NeoplasmsHereditary Thyroid CancerThyroid Cancer GeneticsThyroid Cancer Risk
BACKGROUND: Differentiated thyroid carcinoma (DTC) originates from thyroid follicular epithelial cells and belongs to a group of slowly progressing tumors with a relatively good prognosis. However, recurrences and metastases are a serious problem in advanced stages. Furthermore, progression from a well differentiated thyroid carcinoma to an aggressive anaplastic one is possible. The majority of differentiated thyroid carcinomas are sporadic but a few alleles increasing the cancer risk are known. One of them is the c.470 T > C (p.I157T, rs17879961) missense substitution in the CHEK2 gene. AIM OF THE STUDY: The aim of this study was to investigate whether this specific CHEK2 alteration, c.470 T > C, predisposes the Great Poland (Wielkopolska) population to thyroid cancer. METHODS: 602 differentiated thyroid carcinoma patients and 829 controls randomly selected from population were genotyped for the presence of the c.470C allele using pyrosequencing. Hardy-Weinberg Equilibrium (HWE) was tested for both groups by chi-square distribution and Fisher's exact test. The odds ratios (ORs), 95% confidence intervals (CIs), and p-values were calculated using the R software. RESULTS: The results of genotyping showed the presence of the c.470C allele in 51 patients with a frequency of 4.49%, while in a controls in 42 patients with a frequency of 2.53%. We demonstrated that in the Great Poland population the c.470C CHEK2 variant increases the risk of developing differentiated thyroid cancer almost twice (OR = 1.81, p = 0.004). The risk of papillary thyroid carcinoma in female patients homozygous for the c.470C allele was shown to increase almost 13-fold (OR = 12.81, p = 0.019). CONCLUSIONS: Identification of c.470C CHEK2 gene variant ought to be taken into account by healthcare policymakers. Future well-designed and larger population studies are of great value in confirming these findings. Moreover, a combination of genetic factors together with environmental exposures should also be considered.
29
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jiřina Bártková, Zuzana Hořejšı́, Karen Koed et al. · Nature · 2005 · 2.7K citations
Medicine, Cancer Biology, Oncology +16
Scott A. Hundahl, Irvin D. Fleming, Amy M. Fremgen et al. · Cancer · 1998 · 1.8K citations · Full text
Medicine, Oncology, Cancer Control +16
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Satomi Matsuoka · 1998 · 1.3K citations
Hossein Gharib, Enrico Papini, Ralf Paschke et al. · Endocrine Practice · 2010 · 1.1K citations